Sales/Maturities of Investments

$1.30B

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported$1.30Bperiod endingJun 30, 2026

MRK Quarterly Sales/Maturities of Investments ($3.28B → $1.30B)

Quarterly Sales/Maturities of Investments

High-resolution chart · PNG

MRK sales/maturities of investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. Sales/Maturities of Investments — Quarterly (USD)
Period ending	Sales/Maturities of Investments (USD)
Jun 30, 2001	6,741,600,000
Mar 31, 2001	7,732,500,000
Dec 31, 2000	10,541,300,000
Sep 30, 2000	4,267,200,000
Jun 30, 2000	4,410,600,000
Mar 31, 2000	8,448,400,000
Dec 31, 1999	10,913,500,000
Sep 30, 1999	13,061,700,000
Jun 30, 1999	6,671,700,000
Mar 31, 1999	9,661,800,000
Dec 31, 1998	8,654,300,000
Sep 30, 1998	9,538,000,000
Jun 30, 1998	4,500,100,000
Mar 31, 1998	5,926,500,000
Dec 31, 1997	4,038,600,000
Sep 30, 1997	9,073,500,000
Jun 30, 1997	4,982,600,000
Mar 31, 1997	3,980,700,000
Dec 31, 1996	4,966,800,000
Sep 30, 1996	3,919,600,000
Jun 30, 1996	4,636,300,000
Mar 31, 1996	1,556,500,000
Dec 31, 1995	4,309,700,000
Sep 30, 1995	3,274,300,000
Jun 30, 1995	3,345,800,000
Mar 31, 1995	1,500,300,000
Dec 31, 1994	4,381,900,000
Sep 30, 1994	3,214,400,000
Jun 30, 1994	2,372,900,000
Mar 31, 1994	5,113,100,000
Dec 31, 1993	2,368,100,000
Sep 30, 1993	3,473,700,000
Jun 30, 1993	1,996,300,000
Mar 31, 1993	2,025,400,000
Dec 31, 1992	2,121,300,000
Sep 30, 1992	952,600,000
Jun 30, 1992	833,800,000
Mar 31, 1992	1,075,400,000
Dec 31, 1991	2,494,000,000
Sep 30, 1991	2,552,100,000
Jun 30, 1991	1,832,200,000
Mar 31, 1991	1,640,600,000
Dec 31, 1990	2,792,400,000
Sep 30, 1990	1,964,100,000
Jun 30, 1990	2,053,700,000
Mar 31, 1990	1,417,400,000
Dec 31, 1989	3,276,400,000